High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy

Herbert J. Zeh, Donna Perry-Lalley, Mark E. Dudley, Steven A. Rosenberg, James C. Yang

Research output: Contribution to journalArticlepeer-review

354 Scopus citations

Fingerprint

Dive into the research topics of 'High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences